PTC Therapeutics

PTC Therapeutics is a global pharmaceutical company that develops and commercializes medicines for rare genetic disorders, particularly those with limited or no existing treatments. They focus on innovative drug discovery and gene-targeted therapies to improve disease management and patient outcomes. Their approach involves understanding the underlying genetics of diseases to develop personalized treatments, helping patients with conditions such as Duchenne muscular dystrophy and certain metabolic disorders. By advancing scientific research and collaborating with healthcare providers, PTC aims to provide meaningful therapies that address unmet medical needs in rare disease communities.